Cerulean Pharma Inc. 4
4 · Cerulean Pharma Inc. · Filed Jan 9, 2017
Insider Transaction Report
Form 4
BELOFF GREGG
Interim CFO
Transactions
- Award
Stock Option (right to buy)
2017-01-05+50,000→ 50,000 totalExercise: $0.82Exp: 2027-01-04→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 5, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019.